Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Friday, 19 April 2024
Option Care, Inc.
NASDAQ
OPTN
Summary
|
Chart
|
News
|
History
|
More info..
Recent News
More news...
Optinose to Present at the 2018 RBC Capital Markets Healthcare Conference
01:56 | 16/2/18
GlobeNewswire
YARDLEY, Pa., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present ...
more»
Optinose to Present at Leerink Partners 7th Annual Global Healthcare Conference
01:56 | 10/2/18
GlobeNewswire
YARDLEY, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present ...
more»
Does Optinose Incorporated (NASDAQ:OPTN) Have Gas After Even More Sellers ...
00:26 | 4/1/18
Frisco Fastball
More notable recent OptiNose, Inc. (NASDAQ:OPTN) news were published by: Globenewswire.com which released: “Optinose to Report Third Quarter 2017 Financial Results and Operational …” on November 20, 2017, also Marketwatch.
more»
Optinose Reports Third Quarter 2017 Financial Results and Recent Operating ...
10:00 | 28/11/17
GlobeNewswire
YARDLEY, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter ended September ...
more»
Optinose to Report Third Quarter 2017 Financial Results and Operational ...
01:22 | 21/11/17
GlobeNewswire
YARDLEY, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that the Company will report its third quarter 2017 financial results ...
more»
Optinose to Present at Piper Jaffray Healthcare Conference
01:22 | 18/11/17
GlobeNewswire
YARDLEY, Pa., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller will present at the 29 Annual ...
more»
Optinose to Present at Jefferies 2017 London Healthcare Conference
01:56 | 9/11/17
GlobeNewswire
YARDLEY, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller will present at the Jefferies ...
more»
BMO Smells Opportunity In OptiNose
07:03 | 8/11/17
Benzinga
OptiNose's exhalation delivery system, or EDS, which is focused on high and deep intranasal deposition of a drug, offers significant improvement over current nasal sprays and aerosols, Nachman said.
more»
Optinose Expands Leadership Team with Key Hires
01:00 | 31/10/17
GlobeNewswire
YARDLEY, Pa., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced the addition of five key members to the leadership team to drive the ...
more»
Bucks pharma firm completes $138M IPO
02:07 | 19/10/17
Philadelphia Business Journal
Optinose Inc. closed its $138 million stock offering, making it the first local company in the life sciences sector to go public this year.
more»
1
2
3
next»
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%